Slides and webcasts from ESMO Virtual Plenaries are open to all, ESMO Members and free ESMO Account holders, according to the presenters' agreement to release them.
Login and Watch now!
Efficacy of Everolimus in Patients With HR+/HER2- High Risk Early Stage Breast Cancer
The ESMO Virtual Plenaries are freely available to all healthcare professionals working in Oncology.
Programme
Welcome and introduction of the faculty; Scientific background and context
Rebecca Dent, National Cancer Centre Singapore, Singapore
Efficacy of everolimus in patients with HR+/HER2- high risk early stage breast cancer
Thomas Bachelot, Centre Leon Berard, Lyon, France
Perspectives
Peter Schmid, Cancer Research UK Barts Centre - Barts and The London School of Medicine and Dentistry, London, UK
Discussion and Q&A
Faculty and online audience (via chat feature)
